The general market seems ready to continue the DT after yesterday's intraday reversal.
FLML has been forming a base at the $9 level after the last sell off on Aug 23 <g>
bigcharts.marketwatch.com
The short position came down some in the last month, but it is still > 6x its DAV
The stock has had a good size drop since it left the 20 level in July. Revenues have increased at double digit for 4 consecutive Qs. The LTD is moderate & the EL for 2008 is around $0.15/shr vs the $1.60 estimated for 2007.
Today it announced some positive news on its PI of FT-105
Flamel Technologies Announces Positive Results of a Phase I Trial of FT-105 Basal Insulin versus Lantus(R)
Thursday October 18, 9:00 am ET
LYON, France--(BUSINESS WIRE)--Flamel Technologies (NASDAQ:FLML) today announced positive preliminary Phase I data from a trial comparing the safety, tolerability, and long-acting activity of FT-105 versus Lantus®, an approved basal insulin.
FT-105 is a long-acting recombinant insulin formulation that uses a new microparticulate adaptation of Flamel’s proprietary Medusa® nanoparticle delivery system.
Results from the trial showed that FT-105 achieved a sustained release of recombinant human insulin over the course of the 36-hour pharmacodynamic study period.
Pharmacokinetic results indicate that insulin concentrations were sustained for more than 48 hours in subjects following a single dose of FT-105.
Less diurnal variation in insulin concentration was observed in subjects administered FT-105 compared with Lantus.
FT-105 was well tolerated by subjects, especially with respect to local tolerance. No serious adverse events were reported and no patients withdrew from the study due to adverse events.
Flamel is seeking a licensing partner for this product.
Dr. Jonathan Levy, of the Oxford Centre for Diabetes, Endocrinology, and Metabolism commented, "These results demonstrated a sustained, dose-proportional release of recombinant human insulin. These results are promising in that they show that FT-105 provided insulin concentrations that remained stable for the full 48 hours of the study.”
Snip
It seems that it is worth to keep an eye on FLML.<g>
bigcharts.marketwatch.com
Will see if the present base will be good enough for a rally or if it will dip some more to the $5 level, from where it started its run in 2003.<g>
bigcharts.marketwatch.com
Bernard |
